KOHEI KOBATAKE

Last Updated :2024/05/08

Affiliations, Positions
Hiroshima University Hospital(Medical), Assistant Professor
E-mail
kkobatakehiroshima-u.ac.jp

Basic Information

Academic Degrees

  • Hiroshima University

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment II

Research Activities

Academic Papers

  1. Clinical-Bladder cancer Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 40(12), 202212
  2. ★, Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma., Frontiers in oncology, 12, 202212
  3. Two case reports of immune checkpoint therapy on chromophobe renal cell carcinoma with sarcomatoid differentiation, INTERNATIONAL CANCER CONFERENCE JOURNAL, 11(4), 286-291, 202210
  4. ★, DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 40(10), 202210
  5. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity, Cancer Science, 202209
  6. ★, Evaluation of urinary catheters for effective manual bladder washout., Scientific reports, 12(1), 202208
  7. Successful treatment of BK virus-associated severe hemorrhagic cystitis with bilateral single-J ureteral stenting, IJU case reports, 202207
  8. ★, Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction., Clinical cancer research : an official journal of the American Association for Cancer Research, 26(8), 202004
  9. ★, Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer, Oncology Letters, 201503
  10. ★, Effect on hemostasis of an absorbable hemostatic gelatin sponge after transrectal prostate needle biopsy, International Brazilian Journal of Urology, 201503
  11. ★, Advanced testicular cancer associated with life-threatening tumour lysis syndrome and choriocarcinoma syndrome, Canadian Urological Association Journal, 62-64, 201502
  12. UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes., Blood, 137(7), 2021
  13. Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment., Scientific reports, 11(1), 2021
  14. The secondary tumor of the prostate derived from upper tract urothelial carcinoma: An autopsy case., IJU case reports, 4(6), 2021
  15. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma., Oncology, 99(4), 2021
  16. Progress of genome editing technology and developmental biology useful for radiation research., Journal of radiation research, 62(Supplement_1), 2021
  17. P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma., Anticancer research, 41(9), 2021
  18. CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma., Anticancer research, 41(10), 2021
  19. TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer., Urologic oncology, 39(6), 2021
  20. HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer., Biomedicines, 9(8), 2021
  21. [Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging]., Hinyokika kiyo. Acta urologica Japonica, 65(12), 2019
  22. [Infected Pelvic Lymphocele after Robot-Assisted Radical Prostatectomy]., Hinyokika kiyo. Acta urologica Japonica, 65(1), 2019
  23. Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma., Japanese journal of clinical oncology, 48(9), 2018
  24. ★, Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer., International journal of urology : official journal of the Japanese Urological Association, 24(8), 2017
  25. The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor., Urologic oncology, 35(11), 2017
  26. Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis., Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 11(5), 2017
  27. The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma., BJU international, 117(6B), 2016
  28. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons., Journal of surgical education, 73(4), 2016
  29. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons., Journal of surgical education, 73(4), 2016
  30. The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma., BJU international, 117(6B), 2016
  31. Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy., Oncology letters, 8(2), 2014
  32. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima journal of medical sciences, 60(3), 2011